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RESUMO – Introdução: A biópsia do gânglio sentinela é uma técnica reconhecida no tratamento do melanoma maligno. O 
objetivo deste estudo foi caracterizar esta técnica num grupo de doentes com melanoma maligno da cabeça e pescoço tratados 
num centro de referência. Métodos: Foi realizado um estudo unicêntrico, retrospetivo dos doentes com  melanoma maligno 
cutâneo da cabeça e pescoço submetidos a biópsia do gânglio sentinela no Serviço de Cirurgia de Cabeça e Pescoço do Instituto 
Português de Oncologia de Lisboa entre janeiro de 2010 e dezembro de 2017. Foi analisada informação relativa à localiza-
ção do melanoma, identificação do gânglio sentinela, número e localização dos gânglios excisados e presença de metástases. 
Resultados: 98 doentes foram elegíveis para realização de biópsia do gânglio sentinela durante o período de estudo. As loca-
lizações mais frequentes foram o couro cabeludo (24,5%) e a região auricular (23,5%) e as variantes mais frequentes foram o 
melanoma de extensão superficial (40,8%) e o melanoma nodular (30,6%). Foi identificado gânglio sentinela em 78 doentes. 
Foram excisados em média 3,8 gânglios/ doente e em 16,7% dos doentes em mais que um nível ganglionar. Os níveis ganglio-
nares envolvidos foram a parótida (39,8%), o nível II (29,5%) e o nível V (18,2%). Foram identificadas metástases no gânglio 
sentinela em 13 doentes (16,7%). Conclusão: A abordagem cirúrgica do melanoma maligno da cabeça e pescoço é complexa. 
A vascularização linfática redundante pode originar múltiplos gânglios sentinela e em mais que um nível de drenagem e facilitar 
a ocorrência de falsos-negativos com implicação prognóstica. Independentemente do resultado do gânglio sentinela todos os 
doentes devem ter um seguimento cuidadoso. 
PALAVRAS-CHAVE – Biópsia do Gânglio Sentinela; Melanoma; Neoplasias da Cabeça e do Pescoço; Neoplasias da Pele.
Sentinel Lymph Node Biopsy in Head and Neck 
Cutaneous Malignant Melanoma 
ABSTRACT – Introduction: Sentinel lymph node biopsy is the standard of care for cutaneous melanoma, including head and 
neck melanoma. The aim of this study was to analyse and characterize sentinel lymph node biopsy in a population of head and 
neck melanoma patients. Methods: A unicentric, retrospective study on patients with cutaneous head and neck melanoma who 
underwent sentinel lymph node biopsy in the Department of Head and Neck Surgery at the Portuguese Institute of Oncology (IPO) 
Lisbon between January 2010 and December 2017 was performed. The location of primary melanoma, the identification of sentinel 
lymph node, the number of the excised lymph node biopsy, its lymphatic basin origin and the presence of infraclinic metastasis 
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INTRODUCTION
The incidence of cutaneous melanoma is increasing 
more than other cancers.1 Regional metastases are the most 
important prognostic factor for melanoma recurrence and 
survival.2,3
Sentinel lymph node biopsy (SLNB) is considered an effi-
cient and minimally invasive method of staging and is no-
wadays accepted as the gold standard for the diagnosis of 
infraclinic lymph node metastasis.2,4,5 SLNB is recommended 
for cutaneous melanoma with Breslow thickness higher than 
0.8 mm or below 0.8 mm if ulceration is present.2
About twenty percent of all melanomas occur in the 
head and neck region and the poor prognosis linked with 
this tumor site is well known.  The 10 years overall survival 
of cutaneous melanoma located at scalp and cervical re-
gion is about 60%.6,7 The treatment of malignant tumours 
of the head and neck region is a surgical challenge due to 
the difficulty to obtain safe surgical margins in this complex 
anatomic area, and to a laboured diagnosis and surgical 
treatment of regional metastatic disease with the presence 
of vital structures and redundant arborizing lymphatic and 
vascular structures. The lesion of facial nerve during SLNB 
of parotid region is the most important complication of this 
procedure and, therefore, many surgeons perform prefera-
bly a superficial parotidectomy concomitant with SLNB rather 
than isolated intraparotid adenectomy.8 The high density of 
lymph nodes in the head and neck and the proximity to the 
primary tumor may difficult the identification of the sentinel 
lymph node (SLN) by lymphoscintigraphy. Related with this 
rich lymphatic network, lymph node drainage is frequently 
discordant from predicted patterns and drainage to multiple 
sentinel lymph nodes and to multiple lymphatic basins occurs 
in most patients.9,10
All these facts may contribute to higher false-negatives 
sentinel lymph node rates in the head and neck region. The 
global rate of false negatives in the sentinel node is around 
8 to 20%11 and values above 20% are reported in head and 
neck melanomas.12 According to some authors false-negati-
ves are associated with a higher risk of recurrence and me-
tastasis contributing to the worse prognosis of melanoma in 
this location.12
The aim of this study was to analyze SLNB in the popu-
lation of head and neck melanoma patients according to 
success of the surgical technique, the number of the excised 
SLN, its location and the presence of infraclinic metastasis.
MATERIAL AND METHODS
The authors performed a unicentric, retrospective study 
on patients with cutaneous head and neck melanoma trea-
ted in the Department of Head and Neck Surgery at the Por-
tuguese Institute of Oncology (IPO) Lisbon between January 
2010 and December 2017. The inclusion criteria comprised 
pathologically confirmed melanoma of Breslow thichness 
≥	1	mm	or	<	1	mm	with	ulceration	and	high	mitotic	rate.	
Patients with clinical or radiological evidence of regional or 
distant metastatic disease were excluded. Epidemiological, 
clinical and surgical data were collected from electronic and 
paper health records. The authors studied the location of pri-
mary melanoma, the identification of SLN by lymphoscin-
tigraphy, the number of the SLN excised and its lymphatic 
basin origin, the presence of infraclinic metastasis and the 
recurrence. Data evaluation was performed using descriptive 
statistics coefficients and chi-square test.
RESULTS
Data from 166 patients with head and neck cutaneous 
melanoma was analysed. Twenty-seven patients did no fulfil 
melanoma’s thickness criteria for SLNB, 27 patients recei-
ved a primary complete lymph-node dissection due to clini-
cal cervical metastasis observed during preoperative staging, 
four patients received systemic treatment due to distant me-
tastasis at the moment of the diagnosis and 10 patients were 
excluded for other reasons (refusal of SLNB, no clinical con-
ditions). 
Ninety eight patients (mean age of 65.5 ± 17.7 years; 
50% males) were eligible to undergo SLNB during the obser-
vation period.  
Location of the primary melanoma
The most frequent locations of primary melanoma were 
the scalp (24.5%; n=24), the auricular and periauricular 
region (23.5%; n=23) and the malar area (17.3%; n=17) 
(Fig. 1). The most frequent variants of melanoma were the 
superficial spreading melanoma (40.8%; n=40) followed 
by nodular melanoma (30.6%; n=30) and lentigo malig-
na melanoma (23.5%; n=23) (Fig. 2). The median Breslow 
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were analysed. Results: Ninety-eight patients were eligible to undergo sentinel lymph node biopsy during the observation period. 
The most frequent locations of primary melanoma were the scalp (24.5%) and the auricular and periauricular region (23.5%) and 
the most frequent variants were the superficial spreading melanoma (40.8%) and nodular melanoma (30.6%). Sentinel lymph 
node biopsy was successfully executed in 78 patients (79.6%). A mean of 3.8 lymph-nodes per patient were excised and in 16.7% 
sentinel lymph node were excised in more than one lymphatic basin. The sentinel lymph nodes were identified in parotid region 
(39.8%), level II (29.5%) and level V (18.2%). Sentinel lymph node biopsy metastases were detected in 13 patients (16.7%). 
Conclusion: Surgical approach of head and neck cutaneous melanoma is particularly complex. The redundancy of lymphatic 
system, the multiple sentinel lymph node and sentinel lymph node basins influence the sentinel lymph node biopsy success and 
may contribute to high rates of false-negatives with its prognostic implications. All patients should be carefully monitored. 
KEYWORDS – Head and Neck Neoplasms; Melanoma; Sentinel Lymph Node Biopsy; Skin Neoplasms.
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thickness was 3.7 ± 3.7 mm and ulceration was present in 
45.9%.
SLNB procedure
The SLNB procedure involved the marking of SLN using 
an injection of Technetium99 in the primary melanoma loca-
tion the day before the surgery. A lymphoscintigraphy was 
performed to identify SLN localization. Intraoperative iden-
tification of the SLN was then performed using a surgical 
gamma probe. In 20 patients it was not possible to identify 
SLN – in 17 patients it was not identified by lymphoscinti-
graphy and in three patients it was not identified during the 
surgery. The SLNB was successfully executed in 78 patients. 
SLNs overview: number, location, presence of 
metastases
A total of 286 lymph-nodes were excised, including true 
SLNs and other non-sentinel lymph-nodes excised in close 
proximity to the first. A mean of 3.8 ± 3.0 lymph-nodes 
per patients were excised. In 13 patients (16.7%) SLN were 
identified and excised in more than one lymphatic basin. Ac-
cording to Robbins Classification, most of the SLN were iden-
tified in the parotid region (39.8%; n=35), level II (29.5%; 
n=26) and level V (18.2%; n=16) (Fig. 3).
Metastases were detected in 13 out of the 78 patients 
who underwent successful SLNB (16.7%) and in two of these 
patients metastatic SLN were identified in two or more lym-
phatic basins.
Recurrence
During the study period locoregional or distant recurrence 
was detected in 38.5% of patients in the positive SLN group 
and in 15.4% of patients in the negative SLN group (p = 
0.05) (Fig. 4). Recurrence was observed in four out of 20 pa-
tients (20.0%) in whom the sentinel node was not identified.
DISCUSSION
The complexity and redundancy of lymphatic drainage of 
the cervical region was illustrated by the number of lymph-
-nodes excided for patient (> 3 lymph-nodes) and the mul-
tiple SLN basins (16.7% of patients), as reported by other 
reports.9,10,13
As reported by other work groups13 a significant rate of 
patients showed drainage to parotid region and occipital re-
gion beyond the level II, which is classically involved. This 
fact is very important if we consider that for a long period of 
time the primary lymph-node dissection was the first surgical 
approach to head and neck cutaneous melanoma and in 
the majority of patients these areas were not explored. This 
reinforces the importance of SLNB, its impact on melanoma 
prognosis, as demonstrated in the MSLT-1 trial,14 its efficacy 
and safety in head and neck melanoma6,15,16 and its potential 
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Figure 1 - Location of the primary melanoma. 
Figure 2 - Variant of primary melanoma. 
Figure 3 - Sentinel lymph node location. 
Figure 4 - Recurrence according to sentinel lymph node result. 
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role in the selection of patients who may benefit from adju-
vant therapy.      
Lymph-node metastases were identified in 16.7% of the 
studied patients and in two patients were present in multiple 
lymph-node basins. These results are consistent with results 
of other groups: a positive SLN was identified in 19% of pa-
tients in the study by Evrard D et al16 and in about 15.08% in 
the study by de Rosa N et al17(median Breslow thickness 3.01 
mm and 2.53 mm respectively). 
Some authors report a high detection in SLNB with a 
successful technique occurring in more than 90% of the pa-
tients,16,17 but in our study SLN identification was not success-
ful in 20 patients (20.4%). This discrepancy can be explained 
because this study presents the results of a tertiary centre, 
which collects the most complex cases, and many patients 
had high actinic damage and underwent several previous 
surgeries that can alter the lymphatic drainage of the face 
and complicate SLN identification. Compared to other stu-
dies, this series collected an important number of melanomas 
in the periauricular area, close to the parotid lymph-nodes, 
which also could compromise SLN identification.
Redundancy of lymphatic system and complexity of SLNB 
contribute to the relatively high false-negative rate. One im-
portant limitation of this study is its retrospective design and 
also the inability to calculate the number of false negatives 
since in many cases it was not clear in which lymph node 
basin the relapse occurred. As mentioned above, the false-
-negative rate was inversely correlated with prognosis. If we 
add to these patients those who we were unable to identify 
SLN we get a group of patients which would benefit from a 
close surveillance. 
The results about recurrence were not surprising, showing 
a significant difference between patients with positive and 
negative SLN in terms of locoregional and distant recurrence 
as expected. 
CONCLUSION
The occurrence of lymph-node metastases remains one 
of the most important prognostic factors in the treatment of 
malignant melanoma and its diagnosis is absolutely essen-
tial. Head and neck cutaneous melanoma patients belong 
to a distinct group with a particular complexity in respect of 
SLNB technique. Redundancy of lymphatic system, multiple 
SLNs and SLN basins and lymphoscintigraphy limitations in 
SLN identification may contribute to higher rates of false-ne-
gatives, with its prognostic implications. From this perspec-
tive, all patients with cutaneous head and neck melanoma 
should be very closely monitored regardless of the presence 
of SLN metastasis.
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